Global Short Bowel Syndrome(SBS) Drugs Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Short Bowel Syndrome(SBS) Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Short Bowel Syndrome(SBS) Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Short Bowel Syndrome(SBS) Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Short Bowel Syndrome(SBS) Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Short Bowel Syndrome(SBS) Drugs market, reaching US$ million by the year 2028. As for the Europe Short Bowel Syndrome(SBS) Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Short Bowel Syndrome(SBS) Drugs players cover Merck, Takeda, Emmaus Medical, and Ardelyx, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Short Bowel Syndrome(SBS) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Short Bowel Syndrome(SBS) Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Short Bowel Syndrome(SBS) Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Short Bowel Syndrome(SBS) Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Short Bowel Syndrome(SBS) Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Short Bowel Syndrome(SBS) Drugs market, reaching US$ million by the year 2028. As for the Europe Short Bowel Syndrome(SBS) Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Short Bowel Syndrome(SBS) Drugs players cover Merck, Takeda, Emmaus Medical, and Ardelyx, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Short Bowel Syndrome(SBS) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Glucagon-Like Peptide-2(GLP-2)
- Growth Hormone
- Glutamine
- Other
- Hospitals
- Clinics
- Retail Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Takeda
- Emmaus Medical
- Ardelyx
- Naia Pharmaceuticals
- Nutrinia
- OxThera
- Sancilio Pharmaceuticals
- Zealand Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Short Bowel Syndrome(SBS) Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Short Bowel Syndrome(SBS) Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Short Bowel Syndrome(SBS) Drugs by Country/Region, 2017, 2022 & 2028
2.2 Short Bowel Syndrome(SBS) Drugs Segment by Type
2.2.1 Glucagon-Like Peptide-2(GLP-2)
2.2.2 Growth Hormone
2.2.3 Glutamine
2.2.4 Other
2.3 Short Bowel Syndrome(SBS) Drugs Sales by Type
2.3.1 Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Short Bowel Syndrome(SBS) Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Short Bowel Syndrome(SBS) Drugs Sale Price by Type (2017-2022)
2.4 Short Bowel Syndrome(SBS) Drugs Segment by Sale Channel
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Retail Pharmacies
2.5 Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
2.5.1 Global Short Bowel Syndrome(SBS) Drugs Sale Market Share by Sale Channel (2017-2022)
2.5.2 Global Short Bowel Syndrome(SBS) Drugs Revenue and Market Share by Sale Channel (2017-2022)
2.5.3 Global Short Bowel Syndrome(SBS) Drugs Sale Price by Sale Channel (2017-2022)
3 GLOBAL SHORT BOWEL SYNDROME(SBS) DRUGS BY COMPANY
3.1 Global Short Bowel Syndrome(SBS) Drugs Breakdown Data by Company
3.1.1 Global Short Bowel Syndrome(SBS) Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Company (2020-2022)
3.2 Global Short Bowel Syndrome(SBS) Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Short Bowel Syndrome(SBS) Drugs Revenue by Company (2020-2022)
3.2.2 Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Short Bowel Syndrome(SBS) Drugs Sale Price by Company
3.4 Key Manufacturers Short Bowel Syndrome(SBS) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Short Bowel Syndrome(SBS) Drugs Product Location Distribution
3.4.2 Players Short Bowel Syndrome(SBS) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SHORT BOWEL SYNDROME(SBS) DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Short Bowel Syndrome(SBS) Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Short Bowel Syndrome(SBS) Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Short Bowel Syndrome(SBS) Drugs Annual Revenue by Geographic Region
4.2 World Historic Short Bowel Syndrome(SBS) Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Short Bowel Syndrome(SBS) Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Short Bowel Syndrome(SBS) Drugs Annual Revenue by Country/Region
4.3 Americas Short Bowel Syndrome(SBS) Drugs Sales Growth
4.4 APAC Short Bowel Syndrome(SBS) Drugs Sales Growth
4.5 Europe Short Bowel Syndrome(SBS) Drugs Sales Growth
4.6 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Growth
5 AMERICAS
5.1 Americas Short Bowel Syndrome(SBS) Drugs Sales by Country
5.1.1 Americas Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022)
5.1.2 Americas Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022)
5.2 Americas Short Bowel Syndrome(SBS) Drugs Sales by Type
5.3 Americas Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Short Bowel Syndrome(SBS) Drugs Sales by Region
6.1.1 APAC Short Bowel Syndrome(SBS) Drugs Sales by Region (2017-2022)
6.1.2 APAC Short Bowel Syndrome(SBS) Drugs Revenue by Region (2017-2022)
6.2 APAC Short Bowel Syndrome(SBS) Drugs Sales by Type
6.3 APAC Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Short Bowel Syndrome(SBS) Drugs by Country
7.1.1 Europe Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022)
7.1.2 Europe Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022)
7.2 Europe Short Bowel Syndrome(SBS) Drugs Sales by Type
7.3 Europe Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Short Bowel Syndrome(SBS) Drugs by Country
8.1.1 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Type
8.3 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Short Bowel Syndrome(SBS) Drugs
10.3 Manufacturing Process Analysis of Short Bowel Syndrome(SBS) Drugs
10.4 Industry Chain Structure of Short Bowel Syndrome(SBS) Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Short Bowel Syndrome(SBS) Drugs Distributors
11.3 Short Bowel Syndrome(SBS) Drugs Customer
12 WORLD FORECAST REVIEW FOR SHORT BOWEL SYNDROME(SBS) DRUGS BY GEOGRAPHIC REGION
12.1 Global Short Bowel Syndrome(SBS) Drugs Market Size Forecast by Region
12.1.1 Global Short Bowel Syndrome(SBS) Drugs Forecast by Region (2023-2028)
12.1.2 Global Short Bowel Syndrome(SBS) Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Short Bowel Syndrome(SBS) Drugs Forecast by Type
12.7 Global Short Bowel Syndrome(SBS) Drugs Forecast by Sale Channel
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Short Bowel Syndrome(SBS) Drugs Product Offered
13.1.3 Merck Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Takeda
13.2.1 Takeda Company Information
13.2.2 Takeda Short Bowel Syndrome(SBS) Drugs Product Offered
13.2.3 Takeda Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Takeda Main Business Overview
13.2.5 Takeda Latest Developments
13.3 Emmaus Medical
13.3.1 Emmaus Medical Company Information
13.3.2 Emmaus Medical Short Bowel Syndrome(SBS) Drugs Product Offered
13.3.3 Emmaus Medical Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Emmaus Medical Main Business Overview
13.3.5 Emmaus Medical Latest Developments
13.4 Ardelyx
13.4.1 Ardelyx Company Information
13.4.2 Ardelyx Short Bowel Syndrome(SBS) Drugs Product Offered
13.4.3 Ardelyx Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ardelyx Main Business Overview
13.4.5 Ardelyx Latest Developments
13.5 Naia Pharmaceuticals
13.5.1 Naia Pharmaceuticals Company Information
13.5.2 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product Offered
13.5.3 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Naia Pharmaceuticals Main Business Overview
13.5.5 Naia Pharmaceuticals Latest Developments
13.6 Nutrinia
13.6.1 Nutrinia Company Information
13.6.2 Nutrinia Short Bowel Syndrome(SBS) Drugs Product Offered
13.6.3 Nutrinia Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Nutrinia Main Business Overview
13.6.5 Nutrinia Latest Developments
13.7 OxThera
13.7.1 OxThera Company Information
13.7.2 OxThera Short Bowel Syndrome(SBS) Drugs Product Offered
13.7.3 OxThera Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 OxThera Main Business Overview
13.7.5 OxThera Latest Developments
13.8 Sancilio Pharmaceuticals
13.8.1 Sancilio Pharmaceuticals Company Information
13.8.2 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product Offered
13.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sancilio Pharmaceuticals Main Business Overview
13.8.5 Sancilio Pharmaceuticals Latest Developments
13.9 Zealand Pharma
13.9.1 Zealand Pharma Company Information
13.9.2 Zealand Pharma Short Bowel Syndrome(SBS) Drugs Product Offered
13.9.3 Zealand Pharma Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Zealand Pharma Main Business Overview
13.9.5 Zealand Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Short Bowel Syndrome(SBS) Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Short Bowel Syndrome(SBS) Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Short Bowel Syndrome(SBS) Drugs by Country/Region, 2017, 2022 & 2028
2.2 Short Bowel Syndrome(SBS) Drugs Segment by Type
2.2.1 Glucagon-Like Peptide-2(GLP-2)
2.2.2 Growth Hormone
2.2.3 Glutamine
2.2.4 Other
2.3 Short Bowel Syndrome(SBS) Drugs Sales by Type
2.3.1 Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Short Bowel Syndrome(SBS) Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Short Bowel Syndrome(SBS) Drugs Sale Price by Type (2017-2022)
2.4 Short Bowel Syndrome(SBS) Drugs Segment by Sale Channel
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Retail Pharmacies
2.5 Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
2.5.1 Global Short Bowel Syndrome(SBS) Drugs Sale Market Share by Sale Channel (2017-2022)
2.5.2 Global Short Bowel Syndrome(SBS) Drugs Revenue and Market Share by Sale Channel (2017-2022)
2.5.3 Global Short Bowel Syndrome(SBS) Drugs Sale Price by Sale Channel (2017-2022)
3 GLOBAL SHORT BOWEL SYNDROME(SBS) DRUGS BY COMPANY
3.1 Global Short Bowel Syndrome(SBS) Drugs Breakdown Data by Company
3.1.1 Global Short Bowel Syndrome(SBS) Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Company (2020-2022)
3.2 Global Short Bowel Syndrome(SBS) Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Short Bowel Syndrome(SBS) Drugs Revenue by Company (2020-2022)
3.2.2 Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Short Bowel Syndrome(SBS) Drugs Sale Price by Company
3.4 Key Manufacturers Short Bowel Syndrome(SBS) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Short Bowel Syndrome(SBS) Drugs Product Location Distribution
3.4.2 Players Short Bowel Syndrome(SBS) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR SHORT BOWEL SYNDROME(SBS) DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Short Bowel Syndrome(SBS) Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Short Bowel Syndrome(SBS) Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Short Bowel Syndrome(SBS) Drugs Annual Revenue by Geographic Region
4.2 World Historic Short Bowel Syndrome(SBS) Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Short Bowel Syndrome(SBS) Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Short Bowel Syndrome(SBS) Drugs Annual Revenue by Country/Region
4.3 Americas Short Bowel Syndrome(SBS) Drugs Sales Growth
4.4 APAC Short Bowel Syndrome(SBS) Drugs Sales Growth
4.5 Europe Short Bowel Syndrome(SBS) Drugs Sales Growth
4.6 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Growth
5 AMERICAS
5.1 Americas Short Bowel Syndrome(SBS) Drugs Sales by Country
5.1.1 Americas Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022)
5.1.2 Americas Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022)
5.2 Americas Short Bowel Syndrome(SBS) Drugs Sales by Type
5.3 Americas Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Short Bowel Syndrome(SBS) Drugs Sales by Region
6.1.1 APAC Short Bowel Syndrome(SBS) Drugs Sales by Region (2017-2022)
6.1.2 APAC Short Bowel Syndrome(SBS) Drugs Revenue by Region (2017-2022)
6.2 APAC Short Bowel Syndrome(SBS) Drugs Sales by Type
6.3 APAC Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Short Bowel Syndrome(SBS) Drugs by Country
7.1.1 Europe Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022)
7.1.2 Europe Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022)
7.2 Europe Short Bowel Syndrome(SBS) Drugs Sales by Type
7.3 Europe Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Short Bowel Syndrome(SBS) Drugs by Country
8.1.1 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Type
8.3 Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Short Bowel Syndrome(SBS) Drugs
10.3 Manufacturing Process Analysis of Short Bowel Syndrome(SBS) Drugs
10.4 Industry Chain Structure of Short Bowel Syndrome(SBS) Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Short Bowel Syndrome(SBS) Drugs Distributors
11.3 Short Bowel Syndrome(SBS) Drugs Customer
12 WORLD FORECAST REVIEW FOR SHORT BOWEL SYNDROME(SBS) DRUGS BY GEOGRAPHIC REGION
12.1 Global Short Bowel Syndrome(SBS) Drugs Market Size Forecast by Region
12.1.1 Global Short Bowel Syndrome(SBS) Drugs Forecast by Region (2023-2028)
12.1.2 Global Short Bowel Syndrome(SBS) Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Short Bowel Syndrome(SBS) Drugs Forecast by Type
12.7 Global Short Bowel Syndrome(SBS) Drugs Forecast by Sale Channel
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Short Bowel Syndrome(SBS) Drugs Product Offered
13.1.3 Merck Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Takeda
13.2.1 Takeda Company Information
13.2.2 Takeda Short Bowel Syndrome(SBS) Drugs Product Offered
13.2.3 Takeda Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Takeda Main Business Overview
13.2.5 Takeda Latest Developments
13.3 Emmaus Medical
13.3.1 Emmaus Medical Company Information
13.3.2 Emmaus Medical Short Bowel Syndrome(SBS) Drugs Product Offered
13.3.3 Emmaus Medical Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Emmaus Medical Main Business Overview
13.3.5 Emmaus Medical Latest Developments
13.4 Ardelyx
13.4.1 Ardelyx Company Information
13.4.2 Ardelyx Short Bowel Syndrome(SBS) Drugs Product Offered
13.4.3 Ardelyx Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ardelyx Main Business Overview
13.4.5 Ardelyx Latest Developments
13.5 Naia Pharmaceuticals
13.5.1 Naia Pharmaceuticals Company Information
13.5.2 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product Offered
13.5.3 Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Naia Pharmaceuticals Main Business Overview
13.5.5 Naia Pharmaceuticals Latest Developments
13.6 Nutrinia
13.6.1 Nutrinia Company Information
13.6.2 Nutrinia Short Bowel Syndrome(SBS) Drugs Product Offered
13.6.3 Nutrinia Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Nutrinia Main Business Overview
13.6.5 Nutrinia Latest Developments
13.7 OxThera
13.7.1 OxThera Company Information
13.7.2 OxThera Short Bowel Syndrome(SBS) Drugs Product Offered
13.7.3 OxThera Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 OxThera Main Business Overview
13.7.5 OxThera Latest Developments
13.8 Sancilio Pharmaceuticals
13.8.1 Sancilio Pharmaceuticals Company Information
13.8.2 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product Offered
13.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sancilio Pharmaceuticals Main Business Overview
13.8.5 Sancilio Pharmaceuticals Latest Developments
13.9 Zealand Pharma
13.9.1 Zealand Pharma Company Information
13.9.2 Zealand Pharma Short Bowel Syndrome(SBS) Drugs Product Offered
13.9.3 Zealand Pharma Short Bowel Syndrome(SBS) Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Zealand Pharma Main Business Overview
13.9.5 Zealand Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Short Bowel Syndrome(SBS) Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Short Bowel Syndrome(SBS) Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Glucagon-Like Peptide-2(GLP-2)
Table 4. Major Players of Growth Hormone
Table 5. Major Players of Glutamine
Table 6. Major Players of Other
Table 7. Global Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 8. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2022)
Table 9. Global Short Bowel Syndrome(SBS) Drugs Revenue by Type (2017-2022) & ($ million)
Table 10. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Type (2017-2022)
Table 11. Global Short Bowel Syndrome(SBS) Drugs Sale Price by Type (2017-2022) & (USD/Pcs)
Table 12. Global Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 13. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2022)
Table 14. Global Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2017-2022)
Table 15. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Sale Channel (2017-2022)
Table 16. Global Short Bowel Syndrome(SBS) Drugs Sale Price by Sale Channel (2017-2022) & (USD/Pcs)
Table 17. Global Short Bowel Syndrome(SBS) Drugs Sales by Company (2020-2022) & (K Pcs)
Table 18. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Company (2020-2022)
Table 19. Global Short Bowel Syndrome(SBS) Drugs Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Company (2020-2022)
Table 21. Global Short Bowel Syndrome(SBS) Drugs Sale Price by Company (2020-2022) & (USD/Pcs)
Table 22. Key Manufacturers Short Bowel Syndrome(SBS) Drugs Producing Area Distribution and Sales Area
Table 23. Players Short Bowel Syndrome(SBS) Drugs Products Offered
Table 24. Short Bowel Syndrome(SBS) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Short Bowel Syndrome(SBS) Drugs Sales by Geographic Region (2017-2022) & (K Pcs)
Table 28. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share Geographic Region (2017-2022)
Table 29. Global Short Bowel Syndrome(SBS) Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Short Bowel Syndrome(SBS) Drugs Sales by Country/Region (2017-2022) & (K Pcs)
Table 32. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country/Region (2017-2022)
Table 33. Global Short Bowel Syndrome(SBS) Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 36. Americas Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country (2017-2022)
Table 37. Americas Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country (2017-2022)
Table 39. Americas Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 40. Americas Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2022)
Table 41. Americas Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 42. Americas Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2022)
Table 43. APAC Short Bowel Syndrome(SBS) Drugs Sales by Region (2017-2022) & (K Pcs)
Table 44. APAC Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region (2017-2022)
Table 45. APAC Short Bowel Syndrome(SBS) Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Region (2017-2022)
Table 47. APAC Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 48. APAC Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2022)
Table 49. APAC Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 50. APAC Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2022)
Table 51. Europe Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 52. Europe Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country (2017-2022)
Table 53. Europe Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country (2017-2022)
Table 55. Europe Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 56. Europe Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2022)
Table 57. Europe Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 58. Europe Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2022)
Table 59. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 60. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Short Bowel Syndrome(SBS) Drugs
Table 68. Key Market Challenges & Risks of Short Bowel Syndrome(SBS) Drugs
Table 69. Key Industry Trends of Short Bowel Syndrome(SBS) Drugs
Table 70. Short Bowel Syndrome(SBS) Drugs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Short Bowel Syndrome(SBS) Drugs Distributors List
Table 73. Short Bowel Syndrome(SBS) Drugs Customer List
Table 74. Global Short Bowel Syndrome(SBS) Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 75. Global Short Bowel Syndrome(SBS) Drugs Sales Market Forecast by Region
Table 76. Global Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Short Bowel Syndrome(SBS) Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 79. Americas Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Short Bowel Syndrome(SBS) Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. APAC Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Short Bowel Syndrome(SBS) Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Europe Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Short Bowel Syndrome(SBS) Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
Table 87. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Short Bowel Syndrome(SBS) Drugs Sales Forecast by Sale Channel (2023-2028) & (K Pcs)
Table 91. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share Forecast by Sale Channel (2023-2028)
Table 92. Global Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Sale Channel (2023-2028) & ($ Millions)
Table 93. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share Forecast by Sale Channel (2023-2028)
Table 94. Merck Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Merck Short Bowel Syndrome(SBS) Drugs Product Offered
Table 96. Merck Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 97. Merck Main Business
Table 98. Merck Latest Developments
Table 99. Takeda Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Takeda Short Bowel Syndrome(SBS) Drugs Product Offered
Table 101. Takeda Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 102. Takeda Main Business
Table 103. Takeda Latest Developments
Table 104. Emmaus Medical Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Emmaus Medical Short Bowel Syndrome(SBS) Drugs Product Offered
Table 106. Emmaus Medical Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 107. Emmaus Medical Main Business
Table 108. Emmaus Medical Latest Developments
Table 109. Ardelyx Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Ardelyx Short Bowel Syndrome(SBS) Drugs Product Offered
Table 111. Ardelyx Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 112. Ardelyx Main Business
Table 113. Ardelyx Latest Developments
Table 114. Naia Pharmaceuticals Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product Offered
Table 116. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 117. Naia Pharmaceuticals Main Business
Table 118. Naia Pharmaceuticals Latest Developments
Table 119. Nutrinia Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Nutrinia Short Bowel Syndrome(SBS) Drugs Product Offered
Table 121. Nutrinia Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 122. Nutrinia Main Business
Table 123. Nutrinia Latest Developments
Table 124. OxThera Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. OxThera Short Bowel Syndrome(SBS) Drugs Product Offered
Table 126. OxThera Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 127. OxThera Main Business
Table 128. OxThera Latest Developments
Table 129. Sancilio Pharmaceuticals Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product Offered
Table 131. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 132. Sancilio Pharmaceuticals Main Business
Table 133. Sancilio Pharmaceuticals Latest Developments
Table 134. Zealand Pharma Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Zealand Pharma Short Bowel Syndrome(SBS) Drugs Product Offered
Table 136. Zealand Pharma Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 137. Zealand Pharma Main Business
Table 138. Zealand Pharma Latest Developments
Table 1. Short Bowel Syndrome(SBS) Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Short Bowel Syndrome(SBS) Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Glucagon-Like Peptide-2(GLP-2)
Table 4. Major Players of Growth Hormone
Table 5. Major Players of Glutamine
Table 6. Major Players of Other
Table 7. Global Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 8. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2022)
Table 9. Global Short Bowel Syndrome(SBS) Drugs Revenue by Type (2017-2022) & ($ million)
Table 10. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Type (2017-2022)
Table 11. Global Short Bowel Syndrome(SBS) Drugs Sale Price by Type (2017-2022) & (USD/Pcs)
Table 12. Global Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 13. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2022)
Table 14. Global Short Bowel Syndrome(SBS) Drugs Revenue by Sale Channel (2017-2022)
Table 15. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Sale Channel (2017-2022)
Table 16. Global Short Bowel Syndrome(SBS) Drugs Sale Price by Sale Channel (2017-2022) & (USD/Pcs)
Table 17. Global Short Bowel Syndrome(SBS) Drugs Sales by Company (2020-2022) & (K Pcs)
Table 18. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Company (2020-2022)
Table 19. Global Short Bowel Syndrome(SBS) Drugs Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Company (2020-2022)
Table 21. Global Short Bowel Syndrome(SBS) Drugs Sale Price by Company (2020-2022) & (USD/Pcs)
Table 22. Key Manufacturers Short Bowel Syndrome(SBS) Drugs Producing Area Distribution and Sales Area
Table 23. Players Short Bowel Syndrome(SBS) Drugs Products Offered
Table 24. Short Bowel Syndrome(SBS) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Short Bowel Syndrome(SBS) Drugs Sales by Geographic Region (2017-2022) & (K Pcs)
Table 28. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share Geographic Region (2017-2022)
Table 29. Global Short Bowel Syndrome(SBS) Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Short Bowel Syndrome(SBS) Drugs Sales by Country/Region (2017-2022) & (K Pcs)
Table 32. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country/Region (2017-2022)
Table 33. Global Short Bowel Syndrome(SBS) Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 36. Americas Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country (2017-2022)
Table 37. Americas Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country (2017-2022)
Table 39. Americas Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 40. Americas Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2022)
Table 41. Americas Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 42. Americas Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2022)
Table 43. APAC Short Bowel Syndrome(SBS) Drugs Sales by Region (2017-2022) & (K Pcs)
Table 44. APAC Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region (2017-2022)
Table 45. APAC Short Bowel Syndrome(SBS) Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Region (2017-2022)
Table 47. APAC Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 48. APAC Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2022)
Table 49. APAC Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 50. APAC Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2022)
Table 51. Europe Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 52. Europe Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country (2017-2022)
Table 53. Europe Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country (2017-2022)
Table 55. Europe Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 56. Europe Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2022)
Table 57. Europe Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 58. Europe Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2022)
Table 59. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
Table 60. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Short Bowel Syndrome(SBS) Drugs
Table 68. Key Market Challenges & Risks of Short Bowel Syndrome(SBS) Drugs
Table 69. Key Industry Trends of Short Bowel Syndrome(SBS) Drugs
Table 70. Short Bowel Syndrome(SBS) Drugs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Short Bowel Syndrome(SBS) Drugs Distributors List
Table 73. Short Bowel Syndrome(SBS) Drugs Customer List
Table 74. Global Short Bowel Syndrome(SBS) Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 75. Global Short Bowel Syndrome(SBS) Drugs Sales Market Forecast by Region
Table 76. Global Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Short Bowel Syndrome(SBS) Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 79. Americas Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Short Bowel Syndrome(SBS) Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. APAC Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Short Bowel Syndrome(SBS) Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Europe Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Short Bowel Syndrome(SBS) Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
Table 87. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Short Bowel Syndrome(SBS) Drugs Sales Forecast by Sale Channel (2023-2028) & (K Pcs)
Table 91. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share Forecast by Sale Channel (2023-2028)
Table 92. Global Short Bowel Syndrome(SBS) Drugs Revenue Forecast by Sale Channel (2023-2028) & ($ Millions)
Table 93. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share Forecast by Sale Channel (2023-2028)
Table 94. Merck Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Merck Short Bowel Syndrome(SBS) Drugs Product Offered
Table 96. Merck Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 97. Merck Main Business
Table 98. Merck Latest Developments
Table 99. Takeda Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Takeda Short Bowel Syndrome(SBS) Drugs Product Offered
Table 101. Takeda Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 102. Takeda Main Business
Table 103. Takeda Latest Developments
Table 104. Emmaus Medical Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Emmaus Medical Short Bowel Syndrome(SBS) Drugs Product Offered
Table 106. Emmaus Medical Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 107. Emmaus Medical Main Business
Table 108. Emmaus Medical Latest Developments
Table 109. Ardelyx Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Ardelyx Short Bowel Syndrome(SBS) Drugs Product Offered
Table 111. Ardelyx Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 112. Ardelyx Main Business
Table 113. Ardelyx Latest Developments
Table 114. Naia Pharmaceuticals Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product Offered
Table 116. Naia Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 117. Naia Pharmaceuticals Main Business
Table 118. Naia Pharmaceuticals Latest Developments
Table 119. Nutrinia Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Nutrinia Short Bowel Syndrome(SBS) Drugs Product Offered
Table 121. Nutrinia Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 122. Nutrinia Main Business
Table 123. Nutrinia Latest Developments
Table 124. OxThera Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. OxThera Short Bowel Syndrome(SBS) Drugs Product Offered
Table 126. OxThera Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 127. OxThera Main Business
Table 128. OxThera Latest Developments
Table 129. Sancilio Pharmaceuticals Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Product Offered
Table 131. Sancilio Pharmaceuticals Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 132. Sancilio Pharmaceuticals Main Business
Table 133. Sancilio Pharmaceuticals Latest Developments
Table 134. Zealand Pharma Basic Information, Short Bowel Syndrome(SBS) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Zealand Pharma Short Bowel Syndrome(SBS) Drugs Product Offered
Table 136. Zealand Pharma Short Bowel Syndrome(SBS) Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 137. Zealand Pharma Main Business
Table 138. Zealand Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Short Bowel Syndrome(SBS) Drugs
Figure 2. Short Bowel Syndrome(SBS) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Short Bowel Syndrome(SBS) Drugs Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Short Bowel Syndrome(SBS) Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Glucagon-Like Peptide-2(GLP-2)
Figure 10. Product Picture of Growth Hormone
Figure 11. Product Picture of Glutamine
Figure 12. Product Picture of Other
Figure 13. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type in 2021
Figure 14. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Type (2017-2022)
Figure 15. Short Bowel Syndrome(SBS) Drugs Consumed in Hospitals
Figure 16. Global Short Bowel Syndrome(SBS) Drugs Market: Hospitals (2017-2022) & (K Pcs)
Figure 17. Short Bowel Syndrome(SBS) Drugs Consumed in Clinics
Figure 18. Global Short Bowel Syndrome(SBS) Drugs Market: Clinics (2017-2022) & (K Pcs)
Figure 19. Short Bowel Syndrome(SBS) Drugs Consumed in Retail Pharmacies
Figure 20. Global Short Bowel Syndrome(SBS) Drugs Market: Retail Pharmacies (2017-2022) & (K Pcs)
Figure 21. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2022)
Figure 22. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Sale Channel in 2021
Figure 23. Short Bowel Syndrome(SBS) Drugs Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Company in 2021
Figure 25. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Geographic Region in 2021
Figure 27. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region (2017-2022)
Figure 28. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country/Region in 2021
Figure 29. Americas Short Bowel Syndrome(SBS) Drugs Sales 2017-2022 (K Pcs)
Figure 30. Americas Short Bowel Syndrome(SBS) Drugs Revenue 2017-2022 ($ Millions)
Figure 31. APAC Short Bowel Syndrome(SBS) Drugs Sales 2017-2022 (K Pcs)
Figure 32. APAC Short Bowel Syndrome(SBS) Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Europe Short Bowel Syndrome(SBS) Drugs Sales 2017-2022 (K Pcs)
Figure 34. Europe Short Bowel Syndrome(SBS) Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales 2017-2022 (K Pcs)
Figure 36. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Americas Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country in 2021
Figure 38. Americas Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country in 2021
Figure 39. United States Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region in 2021
Figure 44. APAC Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Regions in 2021
Figure 45. China Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country in 2021
Figure 52. Europe Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country in 2021
Figure 53. Germany Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country in 2021
Figure 60. Egypt Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Short Bowel Syndrome(SBS) Drugs in 2021
Figure 66. Manufacturing Process Analysis of Short Bowel Syndrome(SBS) Drugs
Figure 67. Industry Chain Structure of Short Bowel Syndrome(SBS) Drugs
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 1. Picture of Short Bowel Syndrome(SBS) Drugs
Figure 2. Short Bowel Syndrome(SBS) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Short Bowel Syndrome(SBS) Drugs Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Short Bowel Syndrome(SBS) Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Short Bowel Syndrome(SBS) Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Glucagon-Like Peptide-2(GLP-2)
Figure 10. Product Picture of Growth Hormone
Figure 11. Product Picture of Glutamine
Figure 12. Product Picture of Other
Figure 13. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Type in 2021
Figure 14. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Type (2017-2022)
Figure 15. Short Bowel Syndrome(SBS) Drugs Consumed in Hospitals
Figure 16. Global Short Bowel Syndrome(SBS) Drugs Market: Hospitals (2017-2022) & (K Pcs)
Figure 17. Short Bowel Syndrome(SBS) Drugs Consumed in Clinics
Figure 18. Global Short Bowel Syndrome(SBS) Drugs Market: Clinics (2017-2022) & (K Pcs)
Figure 19. Short Bowel Syndrome(SBS) Drugs Consumed in Retail Pharmacies
Figure 20. Global Short Bowel Syndrome(SBS) Drugs Market: Retail Pharmacies (2017-2022) & (K Pcs)
Figure 21. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Sale Channel (2017-2022)
Figure 22. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Sale Channel in 2021
Figure 23. Short Bowel Syndrome(SBS) Drugs Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Company in 2021
Figure 25. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Geographic Region in 2021
Figure 27. Global Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region (2017-2022)
Figure 28. Global Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country/Region in 2021
Figure 29. Americas Short Bowel Syndrome(SBS) Drugs Sales 2017-2022 (K Pcs)
Figure 30. Americas Short Bowel Syndrome(SBS) Drugs Revenue 2017-2022 ($ Millions)
Figure 31. APAC Short Bowel Syndrome(SBS) Drugs Sales 2017-2022 (K Pcs)
Figure 32. APAC Short Bowel Syndrome(SBS) Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Europe Short Bowel Syndrome(SBS) Drugs Sales 2017-2022 (K Pcs)
Figure 34. Europe Short Bowel Syndrome(SBS) Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales 2017-2022 (K Pcs)
Figure 36. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Americas Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country in 2021
Figure 38. Americas Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country in 2021
Figure 39. United States Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Short Bowel Syndrome(SBS) Drugs Sales Market Share by Region in 2021
Figure 44. APAC Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Regions in 2021
Figure 45. China Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country in 2021
Figure 52. Europe Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country in 2021
Figure 53. Germany Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Short Bowel Syndrome(SBS) Drugs Revenue Market Share by Country in 2021
Figure 60. Egypt Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Short Bowel Syndrome(SBS) Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Short Bowel Syndrome(SBS) Drugs in 2021
Figure 66. Manufacturing Process Analysis of Short Bowel Syndrome(SBS) Drugs
Figure 67. Industry Chain Structure of Short Bowel Syndrome(SBS) Drugs
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
